HomeCompareRHHVF vs JEPQ

RHHVF vs JEPQ: Dividend Comparison 2026

RHHVF yields 3.09% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $12.1K in total portfolio value
10 years
RHHVF
RHHVF
● Live price
3.09%
Share price
$403.29
Annual div
$12.47
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.7K
Annual income
$2,296.61
Full RHHVF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — RHHVF vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHHVFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHHVF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHHVF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHHVF
Annual income on $10K today (after 15% tax)
$262.77/yr
After 10yr DRIP, annual income (after tax)
$1,952.12/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, RHHVF beats the other by $122.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHHVF + JEPQ for your $10,000?

RHHVF: 50%JEPQ: 50%
100% JEPQ50/50100% RHHVF
Portfolio after 10yr
$38.7K
Annual income
$2,224.59/yr
Blended yield
5.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RHHVF right now

RHHVF
Analyst Ratings
3
Buy
5
Hold
1
Sell
Consensus: Hold
Altman Z
5.5
Piotroski
7/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHHVF buys
0
JEPQ buys
0
No recent congressional trades found for RHHVF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHHVFJEPQ
Forward yield3.09%11.10%
Annual dividend / share$12.47$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17%0%
Portfolio after 10y$32.7K$44.8K
Annual income after 10y$2,296.61$2,152.59
Total dividends collected$10.5K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RHHVF vs JEPQ ($10,000, DRIP)

YearRHHVF PortfolioRHHVF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$11,062$361.70$11,930$1,110.39$868.00JEPQ
2$12,274$437.50$14,133$1,224.34$1.9KJEPQ
3$13,663$530.79$16,632$1,340.46$3.0KJEPQ
4$15,266$646.13$19,454$1,457.97$4.2KJEPQ
5$17,124$789.38$22,626$1,576.08$5.5KJEPQ
6$19,291$968.20$26,175$1,694.09$6.9KJEPQ
7$21,834$1,192.66$30,133$1,811.32$8.3KJEPQ
8$24,838$1,476.03$34,531$1,927.17$9.7KJEPQ
9$28,413$1,836.07$39,403$2,041.08$11.0KJEPQ
10$32,699$2,296.61$44,787$2,152.59$12.1KJEPQ

RHHVF vs JEPQ: Complete Analysis 2026

RHHVFStock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Full RHHVF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this RHHVF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHHVF vs SCHDRHHVF vs JEPIRHHVF vs ORHHVF vs KORHHVF vs MAINRHHVF vs XYLDRHHVF vs QYLDRHHVF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.